CrossRef
Works that cite this article, indexed by Crossref.
Metformin addition to androgen deprivation therapy effect on cancer prostate patients with type 2 diabetes
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15(5) (2021)
Engy M. Aboelnaga; Mohamed M. Aboelnaga; Hend MHR. Elkalla
Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
Journal of Experimental & Clinical Cancer Research 38(1) (2019)
Yanju Wu; Qianqian Zheng; Yan Li; Guang Wang; Shuting Gao; Xiaodong Zhang; Xu Yan; Xinwen Zhang; Jisheng Xie; Yuanyuan Wang; Xun Sun; Xin Meng; Bo Yin; Biao Wang
The Effect of Metformin on Bladder Cancer Incidence and Outcomes: A Systematic Review and Meta-Analysis
Bladder Cancer 8(2) (2022)
Jons W. van Hattum; Ben Max de Ruiter; Jorg R. Oddens; Theo M. de Reijke; Johanna W. Wilmink; Remco J. Molenaar
Impact of metformin on recurrence and progression in nonmuscle invasive bladder cancer
Developments and Experiments in Health and Medicine 40(2) (2026)
Muhammed Selçuk Özer; Volkan Şen; Sümeyye Terzi; Ozan Bozkurt; Ömer Demir; Güven Aslan; Mehmet Uğur Mungan; İlhan Çelebi; Ahmet Adil Esen
Expression of miR‑490‑5p, miR‑148a‑3p and miR‑608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells
Oncology Letters (2019)
Min Xiang; Wuxiong Yuan; Weiwei Zhang; Jie Huang
A study of oral metformin for the intravesical treatment of non‐muscle‐invasive bladder cancer
BJU International 136(4) (2025)
Jons W. van Hattum; Marinka J. Remmelink; Sieb T. Nuijens; Ben Max de Ruiter; Gerrit K.J. Hooijer; Jorg R. Oddens; C. Dilara Savci‐Heijink; Ron Mathot; J. Alfred Witjes; Michael .N. Pollak; Theo M. de Reijke; Remco J. Molenaar; Hanneke W. Wilmink